SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-022707
Filing Date
2024-02-02
Accepted
2024-02-02 13:25:31
Documents
14
Period of Report
2024-02-02
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d769447d8k.htm   iXBRL 8-K 23451
  Complete submission text file 0001193125-24-022707.txt   145082

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nexi-20240202.xsd EX-101.SCH 2826
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20240202_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20240202_pre.xml EX-101.PRE 11242
16 EXTRACTED XBRL INSTANCE DOCUMENT d769447d8k_htm.xml XML 3662
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 24589977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)